This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: I44 (atrioventricular and left bundle-branch block) | Special Copayment Reduction: V192 (special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Atrioventricular block (AVB), first-, second- and third-degree (complete) AV block, left bundle branch block (LBBB), left anterior fascicular block (LAFB), left posterior fascicular block (LPFB), His bundle block, bifascicular block, trifascicular block |
| C. Clinical significance | First- and second-degree AV block are mostly asymptomatic, but complete AV block is an important clinical problem causing syncope and sudden death in the elderly and in patients with underlying heart disease. Left bundle branch block is a cause of dyssynchrony in heart failure. |
| 1. History | Description of Stokes-Adams attacks (19th century), invention of the electrocardiogram and recognition of AV block, development of the artificial pacemaker (1958), advances in CRT and physiological pacing |
| 2. Causes | Degenerative fibrosis (Lev and Lenègre disease), ischemic heart disease, infiltrative disease, postoperative, Lyme disease, drugs (digoxin, beta-blockers), congenital |
| 3. Genetics | Conduction disorders with variants in SCN5A (sodium channel), LMNA (lamin A/C), SCN1B and GJA5 (connexin 40); LMNA association with Emery-Dreifuss muscular dystrophy |
| 4. General epidemiology | First-degree AVB about 1.8% of the general population; complete AVB about 200 per 100,000 population; LBBB prevalence about 0.25–0.6% |
| 5. Pathophysiology | Conduction delay or block due to fibrosis, ischemia or infiltration of the AV node, His bundle and bundle branch fibers; LBBB causes left ventricular dyssynchrony |
| 6. Symptoms | Syncope (Stokes-Adams attacks), presyncope, fatigue, exercise intolerance, palpitations, heart failure symptoms (dyspnea, edema) |
| 7. Signs | Bradycardia, cannon A waves, variable first heart sound, abnormal jugular venous pulsation, signs of heart failure (crackles, edema) |
| 8. Screening | 12-lead ECG; 24–48-hour Holter ECG or implantable loop recorder in high-risk groups (patients with syncope, structural heart disease) |
| 9. Diagnosis | Classification by 12-lead ECG; differentiation of Wenckebach vs Mobitz II; His bundle electrophysiology study (HV interval, infra-His block); echocardiography, MRI |
| 10. Treatment | Complete AVB and symptomatic high-grade AVB: permanent pacemaker (DDD/VVIR); LBBB + heart failure: CRT-P/D; physiological pacing (His bundle pacing, left bundle branch pacing) |
| 11. Prognosis | Unpaced complete AVB: 1-year mortality over 50%; excellent prognosis after pacemaker implantation; LBBB is an independent predictor of cardiovascular death |
| 12. Prevention | Treatment of the underlying disease, avoidance or dose reduction of causative drugs, prevention of conduction system injury during cardiac surgery, Lyme disease prevention, monitoring for conduction disorders after TAVI |
| 13. References | 10 references, including ACC/AHA pacemaker guidelines, ESC cardiac rhythm management guidelines, key CRT clinical trials and recent literature on physiological pacing |
The clinical entity of AV block was first systematically described by the 19th-century Irish physicians Robert Adams (1827) and William Stokes (1846). They described recurrent syncope and convulsive attacks occurring with extreme bradycardia, now called Stokes-Adams attacks. At the time, the link between the heart and syncope was recognized, but the anatomical basis of the atrioventricular conduction system was unknown. In 1893, Wilhelm His Jr. anatomically described the specialized conduction tissue connecting the atria and ventricles (the His bundle), and in 1906 Sunao Tawara clearly elucidated the detailed structure of the AV node and the bundle branches. These achievements made a decisive contribution to establishing the anatomical basis of AV block.
When Willem Einthoven developed the string galvanometer in 1901 and began clinical application in 1903, electrocardiographic classification of AV block became possible. In 1906, Karel Frederik Wenckebach had already described, through pulse observation, the phenomenon of repeated block after progressive conduction delay, which is the prototype of second-degree AV block of the Wenckebach type (Mobitz type I). In 1924, Woldemar Mobitz systematized this electrocardiographically and separately distinguished block occurring without sudden prolongation of the PR interval (Mobitz type II). The ECG pattern of left bundle branch block (LBBB) was first reported around 1915 by Louis Faugères Bishop, G. Bousfield and others, and standardized reading criteria were later established.
The most groundbreaking turning point in the history of treatment was the world's first fully implantable cardiac pacemaker operation performed by Åke Senning in Sweden in 1958. The device, designed by Rune Elmqvist, was implanted in Arne Larsson, who went on to live another 43 years and had his pacemaker replaced 26 times. From the 1960s, demand pacemakers, external defibrillators and dual-chamber pacemakers were developed in succession. In the 1990s, as ventricular dyssynchrony came to be recognized as an important mechanism of heart failure, cardiac resynchronization therapy (CRT) was developed for heart failure patients with left bundle branch block. The COMPANION trial (2004) and CARE-HF trial (2005) proved that CRT significantly reduces mortality and hospitalization in heart failure patients. Since the 2010s, the concept of physiological pacing — His-bundle pacing and left bundle branch area pacing (LBBAP) — has emerged, forming a new treatment paradigm that overcomes the dyssynchrony caused by conventional right ventricular apical pacing.
The causes of AV block and left bundle branch block are broadly divided into degenerative/anatomical, ischemic, infiltrative/inflammatory, iatrogenic and congenital causes. The most common cause in clinical practice is age-related fibrosis of the conduction system. Lev disease is characterized by fibrosis and calcification of the AV node and His bundle and is mainly associated with calcification of the aortic and mitral valve annulus, occurring in the elderly. Lenègre disease (Lenègre-Lev disease) is primary degenerative fibrosis and sclerosis of the conduction system itself; it also occurs at relatively young ages, and familial forms are associated with SCN5A variants. These two diseases are the most common causes of complete AV block in adults.
Ischemic heart disease is an important cause of AV block; in particular, inferior myocardial infarction due to right coronary artery (RCA) occlusion cuts off blood flow to the AV node, causing transient or permanent AV block. Complete AV block occurs in about 10–15% of inferior myocardial infarctions; most cases are reversible, but some require a permanent pacemaker. Anterior myocardial infarction can cause block at the level of the His bundle or bundle branches, in which case the prognosis is poor and it is an indication for a permanent pacemaker.
Cardiac sarcoidosis is the representative infiltrative/inflammatory cause. Sarcoidosis causes complete AV block or ventricular arrhythmias through granulomatous infiltration of the conduction system and must be ruled out whenever unexplained AV block is found in a young adult. Lyme carditis (Borrelia burgdorferi infection) is an important reversible cause of AV block in the northeastern United States, and most cases recover after antibiotic treatment. Myocarditis, rheumatoid arthritis, systemic lupus erythematosus and Chagas disease (Trypanosoma cruzi infection) can also cause conduction disorders. AV block after TAVI (transcatheter aortic valve implantation) has recently emerged as an important iatrogenic cause, with an incidence of about 10–25% depending on the device type. Conduction system injury during cardiac surgery (aortic/mitral valve replacement, ventricular septal defect closure, etc.) and complications of catheter ablation are also included. Among drug-related causes, digoxin toxicity, beta-blockers, calcium channel blockers (verapamil, diltiazem), amiodarone and antiarrhythmic drugs suppress AV conduction. Congenital complete AV block occurs when maternal anti-Ro/anti-La antibodies damage the fetal conduction system or in association with structural cardiac malformations (congenitally corrected transposition of the great arteries, etc.).
The genetic basis of AV block and left bundle branch block has been rapidly elucidated over the past 20 years or so. The most important gene is SCN5A, which encodes the alpha subunit of the cardiac sodium channel (Nav1.5). Loss-of-function SCN5A variants cause Brugada syndrome, progressive cardiac conduction disease (PCCD, the genetic form of Lenègre-Lev disease), sinus node dysfunction and other conditions. PCCD in particular is inherited in an autosomal dominant manner and is characterized by gradual progression of conduction disturbances with age. Carriers of SCN5A variants may develop bundle branch block and AV block even at a young age, and a Brugada phenotype may coexist.
LMNA (lamin A/C) encodes a nuclear envelope protein, and LMNA variants cause Emery-Dreifuss muscular dystrophy, lipodystrophy and dilated cardiomyopathy. In the heart, AV block and sinus node dysfunction often appear before the muscular symptoms of muscular dystrophy, and because the risk of ventricular arrhythmias and sudden death is high, prophylactic ICD implantation is discussed as an indication. Cardiac conduction disease associated with LMNA variants typically presents as AV block in the 20s–40s. In addition, GJA5 encodes connexin 40, the main gap junction protein of the atria, and GJA5 variants are associated with atrial fibrillation and cardiac conduction disorders.
SCN1B encodes the sodium channel beta-1 subunit, and loss-of-function variants are associated with Brugada syndrome and conduction disorders. KCNK17, HCN4 (hyperpolarization-activated cyclic nucleotide-gated channel) and TBX5 (a transcription factor) are also attracting attention as genes affecting the development of the cardiac conduction system and conduction velocity. TBX5 is essential for cardiac development and differentiation of the conduction system and is associated with Holt-Oram syndrome. Genome-wide association studies (GWAS) have found many loci associated with ECG parameters such as the PR interval and QRS duration, and polygenic risk scores are beginning to be used to predict AV block and atrial fibrillation. Genetic panel testing is recommended for patients with unexplained high-grade AV block (especially under age 40).
The prevalence of AV block varies greatly with the degree of block and the population studied. First-degree AV block (PR interval >200 ms) has a prevalence of about 1.5–2.0% in the general adult population and is more common in the elderly and in trained athletes with high vagal tone. Large cohorts, including the Framingham Heart Study, have shown first-degree AV block to be an independent predictor of atrial fibrillation, heart failure and mortality. Second-degree AV block is rare in the general population, and the Wenckebach type (Mobitz type I) is much more common than Mobitz type II. Mobitz type II is rare but carries a high risk of progression to complete AV block, giving it great clinical significance.
The population-based incidence of third-degree (complete) AV block is estimated at about 100–200 per 100,000 population, rising sharply with age. In the United States, about 150,000 pacemaker implantations are performed each year, the main indication being high-grade AV block. Congenital complete AV block occurs in about 1–2 per 10,000 births. The prevalence of left bundle branch block (LBBB) increases with age, from about 0.1% under age 40 to about 0.5% in the 60s and about 0.9–2.0% at age 80 and older, and is estimated at about 0.25–0.6% among all adults. LBBB prevalence is significantly higher in patients with hypertension, coronary artery disease and dilated cardiomyopathy than in the general population. Left anterior fascicular block (LAFB) is the most common bundle branch block, observed in about 1–5% of adults. By sex, men show a slightly higher prevalence of LBBB and complete AV block.
Domestic epidemiological data include studies using National Health Insurance Service (NHIS) data; as of the 2010s, the annual incidence of permanent pacemaker implantation was reported to be about 60–80 per 100,000 population, somewhat lower than in Western Europe (100–150). This is analyzed as reflecting differences in access, awareness and criteria for determining indications. With the increase in TAVI procedures, pacemaker implantation for post-procedural AV block has recently been increasing markedly.
The cardiac conduction system transmits electrical excitation in the sequence sinoatrial node (SA node) → atrioventricular node (AV node) → His bundle → left bundle branch (LBB) and right bundle branch (RBB) → Purkinje fiber network. The AV node, as the only normal conduction pathway between the atria and ventricles, provides a conduction delay (AV delay) so that ventricular filling is completed after atrial contraction. AV block occurs when conduction is delayed or blocked at any level of this system.
First-degree AV block is a state in which the PR interval exceeds 200 ms, mostly due to conduction delay at the level of the AV node. Because in AV nodal cells the L-type calcium channel (ICa,L) rather than the sodium channel carries the main depolarizing current, conduction is easily delayed by calcium channel blockers, increased parasympathetic tone and the like. Second-degree AV block of the Wenckebach type (Mobitz I) is understood as a progressive fatigue phenomenon in the AV node, showing a pattern in which conduction delay increases with each beat until one P wave is not conducted, after which conduction recovers. Mobitz type II is block at the infra-His level, in which a P wave is suddenly blocked without progressive change in the PR interval. In this region the fascicles are narrow and the blood supply is vulnerable, so the risk of progression to complete block is high.
Third-degree (complete) AV block is a state in which no atrial impulses are transmitted to the ventricles, and the ventricles are driven by an escape pacemaker below the AV node. The higher the location of the escape pacemaker (near the AV node), the faster the rate (40–60/min) and the narrower the QRS; the lower it is (within the ventricles), the slower the rate (20–40/min) and the wider the QRS, making it hemodynamically unstable. In left bundle branch block (LBBB), conduction in the left bundle is blocked, so the left ventricle is activated by slow conduction via the right bundle → Purkinje system → myocardial cells. This causes electrical and mechanical dyssynchrony of the left ventricle, with interventricular, intraventricular and atrioventricular dyssynchrony occurring in combination. Chronic LBBB causes ventricular remodeling, diastolic dysfunction and secondary mitral regurgitation, forming a vicious cycle that worsens heart failure.
The pattern and severity of symptoms vary greatly with the degree of AV block, the location and stability of the escape pacemaker, and baseline cardiac function. First-degree AV block is almost always asymptomatic and found incidentally on ECG. However, when the PR interval is very long (>300 ms), atrial contraction occurs in early ventricular relaxation, and a de facto 'first-degree block syndrome' (pacemaker syndrome analog) may develop. In this case, symptoms may improve when a pacemaker is implanted to optimize the AV interval.
Second-degree AV block can cause palpitations felt as dropped beats, intermittent dizziness and fatigue. In Mobitz type II and high-degree AV block (2:1, 3:1 or higher), the effective heart rate falls and distinct symptoms of bradycardia appear. The most characteristic and dangerous symptom of third-degree (complete) AV block is the Stokes-Adams attack. This is a sudden loss of consciousness occurring when the heart stops for a few seconds to tens of seconds until an escape pacemaker is activated at the onset of complete block, sometimes accompanied by convulsions. Transition to ventricular tachycardia or fibrillation may occur and can cause sudden death.
Other symptoms of complete AV block include chronic fatigue, exercise intolerance (loss of heart rate response during exercise) and dyspnea, and cardiogenic shock may occur if the escape pacemaker is slow and unstable. Left bundle branch block itself does not cause symptoms, but if underlying structural heart disease or heart failure is present, heart failure symptoms such as dyspnea, edema and reduced exercise capacity appear. In addition, when left bundle branch block occurs together with myocardial infarction, it makes the diagnosis of infarction difficult and risks delaying reperfusion therapy; the Sgarbossa criteria or modified Sgarbossa criteria are therefore used so that such cases are regarded as 'acute myocardial infarction with LBBB (STEMI equivalent)' and prompt coronary intervention is performed.
On physical examination, signs of AV block vary with the type and degree of arrhythmia and baseline cardiac function. Bradycardia is the most prominent sign in complete or high-grade AV block; the heart rate is 30–60/min (depending on the location of the escape pacemaker) and regular. Severe bradycardia lowers blood pressure and is accompanied by pallor, cold sweats and altered consciousness.
On jugular venous examination, cannon A waves are the most specific of the pathological signs of complete AV block. Because the atria and ventricles contract independently, when atrial contraction happens to occur while the tricuspid valve is closed, blood ejected by the atrial contraction flows back into the jugular vein, and tall pulsations are intermittently observed in the neck. These cannon A waves appear irregularly and are an important bedside diagnostic clue to complete AV block. A variable first heart sound (variable S1) is also characteristic of complete AV block: as the atrioventricular relationship changes, the closing velocity and filling of the mitral and tricuspid valves vary, so the intensity of S1 changes with each beat. A beat with a very loud S1 is called a 'cannon first heart sound.'
In left bundle branch block, paradoxical splitting of S2 may be heard on auscultation. Normally, S2 splits on inspiration because the aortic valve closes before the pulmonary valve, but in LBBB, delayed left ventricular activation causes the aortic valve to close later than the pulmonary valve, producing paradoxical splitting that becomes more pronounced on expiration. If heart failure is present, rales, elevated jugular venous pressure, lower-limb edema, hepatomegaly and an S3 gallop rhythm may be observed. In second-degree AV block, a pattern in which heartbeats intermittently drop out on auscultation and then continue regularly without a compensatory pause is characteristic (Wenckebach type: dropped beat after progressively shortening RR intervals; Mobitz type II: sudden dropped beat).
The first-line screen for AV block and bundle branch block is the 12-lead electrocardiogram (ECG). The 12-lead ECG is noninvasive and inexpensive and is sufficient to accurately classify the type and degree of AV block. Simply reading the PR interval, QRS duration and axis deviation routinely in asymptomatic patients can detect important conduction disorders early. A 12-lead ECG is essential particularly in preoperative evaluation, workplace health checkups and follow-up of high-risk groups (history of hypertension, diabetes, coronary artery disease).
When intermittent arrhythmia or syncope is suspected, a 24–48-hour Holter ECG is recommended. Holter monitoring is useful for capturing episodes of AV block during daily activities and quantifying maximum and minimum heart rates, pauses and so on. When symptoms occur infrequently, an event monitor, a long-term patch recorder (Zio patch, etc.) or an implantable loop recorder (ILR) is used. An ILR is implanted subcutaneously for up to 3 years and is effective in identifying the cause of intermittent syncope; in the PICTURE study, the cause of syncope was identified by ILR in 73%.
When exercise-induced AV block is suspected, an exercise stress ECG is performed. A pattern in which AV block worsens during exercise suggests an infra-Hisian lesion and carries a poor prognosis (normally, AV conduction improves during exercise owing to parasympathetic withdrawal). To rule out structural heart disease, echocardiography, cardiac MRI and gallium scan or 18F-FDG PET (when cardiac sarcoidosis is suspected) are used as additional screening tests. In patients with AV block in Lyme disease-endemic areas, serum Borrelia antibody testing is an essential screening item. For unexplained AV block in young patients, genetic panel testing and autoantibody testing (anti-Ro, anti-La) are recommended.
The 12-lead ECG is the key tool for classifying AV block. First-degree AV block is when the PR interval exceeds 200 ms while the P-QRS relationship is maintained for every P wave. Second-degree AV block of the Wenckebach type shows a repeating pattern in which the PR interval progressively lengthens until a P wave is not conducted (dropped QRS), then starts again with a short PR interval. Mobitz type II is a pattern in which a P wave is suddenly not conducted without change in the PR interval; the QRS is often wide, strongly suggesting an infra-His lesion. 2:1 AV block is a form in which one of every two P waves is not conducted; Mobitz I/II cannot be distinguished from this ECG finding alone, and an electrophysiology study may be needed. Third-degree (complete) AV block is characterized by AV dissociation, in which P waves and QRS complexes appear completely independently.
The ECG diagnostic criteria for left bundle branch block (LBBB) are a QRS duration ≥120 ms, a broad, deep S wave or rS/QS pattern in V1, broad, notched R waves in V5, V6, I and aVL, and absent S waves in V5 and V6. Distinguishing complete LBBB from incomplete LBBB (QRS 100–119 ms) is also important. The Sgarbossa criteria are ECG criteria for diagnosing acute myocardial infarction in the presence of LBBB and include ST elevation ≥1 mm concordant with the QRS, ST depression ≥1 mm in V1–V3, and ST elevation ≥5 mm discordant with the QRS.
An invasive electrophysiology study (EPS), performed when high-grade AV block or an infra-His lesion is suspected, directly records the His bundle potential (His electrogram) to determine precisely the anatomical location of AV block. The AH interval (AV nodal conduction time, normal 55–130 ms) and HV interval (His–ventricular conduction time, normal 35–55 ms) are measured. An HV interval ≥70 ms suggests a risk of progressive complete block, and ≥100 ms is regarded as an indication for pacemaker implantation. In 2:1 AV block, EPS is essential to distinguish intra-His from infra-His block. Cardiac MRI (analysis of late gadolinium enhancement patterns) to differentiate cardiac sarcoidosis, LMNA variant-related cardiomyopathy and the like is also part of the diagnostic process.
The goals of treatment for AV block are maintaining cardiac output, relieving symptoms and preventing sudden death, and the treatment depends on the degree and cause of block. Correction of reversible causes comes first. Lyme carditis, drug toxicity and transient AV block after myocardial infarction may recover with treatment of the cause, with temporary pacing used as bridging therapy. AV block due to electrolyte abnormalities (hyperkalemia), hypothyroidism or hypoxia also recovers after correction of the cause.
Implantation of a permanent pacemaker (PPM) is the mainstay of treatment for AV block. Class I indications under the 2018 ACC/AHA/HRS pacemaker guidelines are: (1) third-degree or high-grade AV block (regardless of cause); (2) symptomatic second-degree AV block; (3) Mobitz type II second-degree AV block (with or without symptoms); (4) bilateral bundle branch block (alternating bundle branch block, HV ≥100 ms); (5) infra-His block with syncope. In pacing mode selection, DDD mode, which coordinates atrial sensing and ventricular pacing, is standard, and VVIR mode is used with chronic atrial fibrillation. Because unnecessary right ventricular apical (RV apex) pacing causes ventricular dyssynchrony, minimization algorithms (VVI backup rate, AAI with automated mode switch, atrial preference pacing, etc.) are used. When physiological pacing of the His bundle or left bundle branch is feasible, it is considered first.
Cardiac resynchronization therapy (CRT) is a Class I indication when LBBB (QRS ≥130–150 ms), reduced ejection fraction (EF ≤35%) and NYHA class II–III heart failure are present. CRT-P (resynchronization pacemaker) and CRT-D (resynchronization defibrillator) synchronize the left and right ventricles by positioning a pacing lead in the coronary sinus over the left ventricular lateral wall. In the COMPANION, CARE-HF, MADIT-CRT and RAFT trials, CRT reduced heart failure hospitalization by 40–50% and mortality by 20–40%. His-bundle pacing (HBP) is a physiological pacing method that directly captures the His bundle to activate the ventricles through the normal conduction system, allowing correction of LBBB and prevention of dyssynchrony caused by right ventricular pacing. Left bundle branch area pacing (LBBAP) is a new technique in which the lead is inserted deep into the interventricular septum to capture the distal left bundle, and there are increasing reports that it has lower and more stable thresholds than HBP and a superior ability to correct LBBB.
Prognosis varies greatly with the degree of block, whether it is treated, baseline cardiac function and the stability of the escape pacemaker. First-degree AV block was long regarded as benign, but large studies such as the Framingham Heart Study and the ARIC cohort have shown that PR prolongation is independently associated with a 1.5–2-fold increased risk of atrial fibrillation, heart failure and increased all-cause mortality. In second-degree AV block, the Wenckebach type mostly follows a benign course, but Mobitz type II and high-grade block of 2:1 or more carry a high risk of progression to complete AV block and require active follow-up or pacemaker implantation.
Untreated, complete AV block has a very poor prognosis. In natural history studies before the 1960s, the 1-year mortality of complete AV block exceeded 50%. After permanent pacemaker implantation, the prognosis improves markedly; the life expectancy of paced patients with complete AV block depends on baseline cardiac function but is mostly normal or near normal. However, when underlying cardiomyopathy or structural heart disease is present, progression of heart failure determines the prognosis.
Left bundle branch block is an independent predictor of cardiovascular death even in the general population. New-onset LBBB may be a marker of underlying heart disease, and LBBB accompanied by coronary artery disease or cardiomyopathy carries a high risk of heart failure progression and sudden death. In heart failure patients with LBBB, CRT improves left ventricular ejection fraction by 10–15 percentage points through reverse remodeling, which leads to reduced mortality. The CRT response rate is higher in LBBB patients (~70%) and lower in those with non-LBBB bundle branch block or a narrow QRS. Patients with congenital complete AV block requiring surgical correction can also achieve normal growth, development and quality of life with appropriate pacemaker therapy.
Prevention of AV block and left bundle branch block requires a cause-specific approach. The most effective prevention is active management of underlying cardiovascular disease. Thorough control of hypertension, diabetes and dyslipidemia reduces coronary artery disease and ischemic conduction disorders. Prompt reperfusion therapy for myocardial infarction minimizes infarct size and prevents conduction complications including AV block. In cardiac surgery (valve replacement, ventricular septal defect repair, etc.), knowing the anatomy of the conduction system and carefully choosing the sites of electrocautery and sutures are important for reducing postoperative permanent AV block.
To prevent drug-induced AV block, the doses of drugs that suppress AV conduction (digoxin, beta-blockers, non-dihydropyridine calcium channel blockers, amiodarone, sotalol) should be minimized, and ECG monitoring should be intensified in elderly patients and those with underlying conduction disorders. Caution is also needed for AV block due to drug interactions (e.g., amiodarone + digoxin). Lyme disease prevention can reduce a reversible cause of AV block in endemic areas, and tick avoidance, tick control and early antibiotic treatment are effective in preventing Lyme carditis.
AV block after TAVI is currently an important prevention challenge. Optimizing device implantation depth, size and type selection, intensifying post-procedural ECG monitoring, and assessing the need for prophylactic pacemaker implantation in patients with pre-existing PR prolongation or left bundle branch block are being discussed. When there is a family history of hereditary conduction disease (SCN5A, LMNA variants), identifying high-risk individuals early through genetic testing and electrophysiological follow-up, and determining the timing of prophylactic pacemaker implantation, are important for preventing sudden death. In cardiac sarcoidosis, early immunosuppressive therapy can slow the progression of conduction disorders but often does not reduce the need for pacemaker and ICD implantation, so ECG follow-up must be continued.